Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical composition and preparation method thereof

A composition and drug technology, applied in the field of medicine, can solve the problem of failing to find and prevent glaucoma, and achieve the effects of good batch-to-batch viscosity uniformity, good stability, and good bacteriostatic effect.

Active Publication Date: 2021-12-07
WUHAN WUYAO SCI & TECH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, no effective way to prevent glaucoma has been found, and intraocular pressure is the only factor that has been proven to be effectively controlled in current glaucoma treatment. Controlling, effectively controlling intraocular pressure and reducing complications is an effective method for the treatment of glaucoma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition and preparation method thereof
  • Pharmaceutical composition and preparation method thereof
  • Pharmaceutical composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0109] The consumption of each raw material of the dorzolamide hydrochloride eye drops of the present embodiment is as follows:

[0110] Dorzolamide hydrochloride 111.3g, sodium citrate dihydrate 14.7g, mannitol 80g, hydroxypropyl cellulose 16.67g, povidone 6.67g, propylene glycol alginate 1.66g, benzalkonium chloride 0.025g, after preparation Add water for injection to make up to 5000mL.

[0111] The preparation method of the dorzolamide hydrochloride eye drops of the present embodiment may further comprise the steps:

[0112] 1) Take water for injection with a total volume of 30%, heat it to keep the water temperature at 80°C, add 16.67g hydroxypropyl cellulose and 6.67g povidone under stirring, and continue stirring for 30min; Sodium citrate hydrate, 80g mannitol, 0.025g benzalkonium chloride, keep the water temperature at 60°C, stir for 20-30min, under stirring, sterilize at 121°C for 15min, cool the liquid to 30°C, then filter and collect filtrate;

[0113] 2) Take wat...

Embodiment 2

[0119] The consumption of each raw material of the dorzolamide hydrochloride eye drops of the present embodiment is as follows:

[0120] Dorzolamide hydrochloride 111.3g, sodium citrate dihydrate 14.7g, mannitol 80g, hydroxypropyl cellulose 12.5g, povidone 10.7g, propylene glycol alginate 1.78g, benzalkonium chloride 0.005g, after preparation Add water for injection to make up to 5000mL.

[0121] The preparation method of the dorzolamide hydrochloride eye drops of the present embodiment may further comprise the steps:

[0122]1) Take water for injection with a total volume of 30%, heat it to keep the water temperature at 80°C, add 12.5g of hydroxypropyl cellulose, 10.7g of povidone, and 0.89g of propylene glycol alginate under stirring, continue stirring for 30min, and then In the state, add 14.7g sodium citrate dihydrate, 80g mannitol, 0.005g benzalkonium chloride, keep the water temperature at 60°C, stir for 20-30min, and sterilize at 121°C for 15min while stirring, and coo...

Embodiment 3

[0129] The consumption of each raw material of the dorzolamide hydrochloride eye drops of the present embodiment is as follows:

[0130] Dorzolamide hydrochloride 111.3g, sodium citrate dihydrate 14.7g, mannitol 80g, hydroxypropyl cellulose 21.44g, povidone 1.78g, propylene glycol alginate 1.78g, benzalkonium chloride 0.05g, after preparation Add water for injection to make up to 5000mL.

[0131] The preparation method of the dorzolamide hydrochloride eye drops of the present embodiment may further comprise the steps:

[0132] 1) Take water for injection with a total volume of 30%, heat it to keep the water temperature at 80°C, add 21.44g hydroxypropyl cellulose, 1.78g povidone, and 0.78g propylene glycol alginate under stirring, and continue stirring for 30 minutes; In the state, add 14.7g sodium citrate dihydrate, 80g mannitol, 0.05g benzalkonium chloride, keep the water temperature at 60°C, stir for 20-30min, sterilize at 121°C for 15min, cool the liquid to 30°C, and then ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
percent by volumeaaaaaaaaaa
Login to View More

Abstract

The invention provides a pharmaceutical composition. The pharmaceutical composition comprises dorzolamide hydrochloride as an active component and a bacteriostatic agent, and the mass ratio of the bacteriostatic agent to the dorzolamide hydrochloride is (0.00004-0.0005): 1. The pharmaceutical composition provided by the invention has the advantages of low concentration of the bacteriostatic agent, small standard deviation of viscosity between batches, high content of effective configuration of active ingredients and good drug stability.

Description

technical field [0001] The present invention relates to the field of medicine. Specifically, the present invention relates to a pharmaceutical composition and a preparation method thereof, more specifically, to a pharmaceutical composition, a preparation method thereof and a dorzolamide hydrochloride preparation. Background technique [0002] Glaucoma is one of the main causes of blindness. The main cause of glaucoma is the blockage of aqueous humor outflow caused by various reasons, resulting in elevated intraocular pressure and optic nerve damage. The main hazards include elevated intraocular pressure, narrowed visual field, and optic nerve damage. Primary glaucoma can be divided into open-angle glaucoma and angle-closure glaucoma. There are about 70 million glaucoma patients in the world, about half of which are in Asia, while the number of glaucoma patients in my country is close to 10 million, which is one of the main blinding eye diseases in our country. There are est...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K47/38A61K47/32A61K47/36A61K47/18A61K31/382A61P27/06
CPCA61K9/0048A61K9/08A61K47/38A61K47/32A61K47/36A61K47/18A61K31/382A61P27/06
Inventor 易筠千李倩吴娟郭婷婷殷晶莉
Owner WUHAN WUYAO SCI & TECH